MedTrace Logo

Effects of Xanthohumol on Metabolic Syndrome Progression

NCT03561116 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2018-06-19

No results posted yet for this study

Summary

A huge body of scientific evidence has suggested that xanthohumol (XAN) consumption, a polyphenol present in beer, has a positive effect on energy metabolism. This compound is known for its antioxidant, anti-inflammatory and anti-cancer properties which confer potential to be used as a food supplement. Nevertheless, XAN lipophilic properties prevent the extensive use of this molecule as a functional food compound. The company TA-XAN S.A.M. (Wiesbaden, Germany) has patented a method to overcome this solubility problem. So, the main aim of this study is to evaluate the effects of XAN consumption on metabolic syndrome progression in individuals recently diagnosed.

Conditions

  • Metabolic Syndrome

Interventions

DIETARY_SUPPLEMENT

XAN

Daily intake of a sachet containing 12 mg of XAN

DIETARY_SUPPLEMENT

Placebo

Daily intake of a sachet containing excipient

Sponsors & Collaborators

  • Universidade do Porto

    lead OTHER

Principal Investigators

  • Raquel Soares, PhD · Medical Faculty of University of Porto

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-19
Primary Completion
2018-09-30
Completion
2018-10-31

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03561116 on ClinicalTrials.gov